Chitosan: poly(N-vinylpyrrolidone-alt-itaconic anhydride) nanocapsules—a promising alternative for the lung cancer treatment
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Dendrimers and Hyperbranched Polymers · Biopolymer Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (27)
Show source-provided references
1. Anton N, Benoit JP, Saulnier P (2008) Design and production of nanoparticles formulated from nanoemulsion templates—a review. J Control Release 128:185–199. doi: 10.1016/j.jconrel.2008.02.00710.1016/j.jconrel.2008.02.007 ↗
2. Barreto JA, O’Malley W, Kubeil M, Graham B, Stephan H, Spiccia L (2011) Nanomaterials: applications in cancer imaging and therapy. Adv Mater 23:H18–H40. doi: 10.1002/adma.20110014010.1002/adma.201100140 ↗
3. Berrabah M, Andre D, Verite P, Zahidi A, Lafont O (2004) Aminoglutethimide included in nanocapsules suspension: comparison of GC–MS and HPLC methods for control. J Pharm Biomed Anal 35:761–768. doi: 10.1016/j.jpba.2004.02.03010.1016/j.jpba.2004.02.030 ↗
4. Blouza IL, Charcosset C, Sfar S, Fessi H (2006) Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use. Int J Pharm 325:124–131. doi: 10.1016/j.ijpharm.2006.06.02210.1016/j.ijpharm.2006.06.022 ↗
5. Boonsongrit Y, Mueller BW, Mitrevej A (2008) Characterization of drug–chitosan interaction by 1H NMR, FTIR and isothermal titration calorimetry. J Pharm Biopharm 69:388–395. doi: 10.1016/j.ejpb.2007.11.00810.1016/j.ejpb.2007.11.008 ↗
6. Cismaru L, Hamaide T, Popa M (2007) Itaconic anhydride based amphiphilic copolymers: synthesis, characterization and stabilization of carboxyl functionalized, PEGylated nanoparticles. Eur Polymer J 43:4843–4851. doi: 10.1016/j.eurpolymj.2007.09.02310.1016/j.eurpolymj.2007.09.023 ↗
7. Cossarizza A, Baccarani-Contri M, Kalashnikova G, Franceschi C (1993) A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun 197:40–45. doi: 10.1006/bbrc.1993.243810.1006/bbrc.1993.2438 ↗
8. Das J, Das S, Samadder A, Bhadra K, Khuda-Bukhsh AR (2012) Poly (lactide-co-glycolide) encapsulated extract of Phytolaccadecandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells. Eur J Pharm Sci 47:313–324. doi: 10.1016/j.ejps.2012.06.01810.1016/j.ejps.2012.06.018 ↗
9. Díaz MR, Vivas-Mejia PE (2013) Nanoparticles as drug delivery systems in cancer medicine: emphasis on RNAi-containing nanoliposomes. Pharmaceuticals 6:1361–1380. doi: 10.3390/ph611136110.3390/ph6111361 ↗
10. Garbuzenko OB, Mainelis G, Taratula O, Minko T (2014) Inhalation treatment of lung cancer: the influence of composition, size and shape of nanocarriers on their lung accumulation and retention. Cancer Biol Med 11:44–55. doi: 10.7497/j.issn.2095-3941.2014.01.004
11. Garcion E, Lamprecht A, Heurtault B, Paillard A, Aubert-Pouessel A, Denizot B, Menei P, Benoît JP (2006) A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 5:1710–172210.1158/1535-7163.MCT-06-0289 ↗
12. Hubbs AF, Mercer RR, Benkovic SA, Harkema J, Sriram K, Schwegler-Berry D, Goravanahally MP, Nurkiewicz TR, Castranova V, Sargent LM (2011) Nanotoxicology—a pathologist’s perspective. Toxicol Pathol 39:301–324. doi: 10.1177/019262331039070510.1177/0192623310390705 ↗
13. Irache JM, Esparza I, Gamazo C, Agueros M, Espuelas S (2011) Nanomedicine: novel approaches in human and veterinary therapeutics. Vet Parasitol 180:47–71. doi: 10.1016/j.vetpar.2011.05.02810.1016/j.vetpar.2011.05.028 ↗
14. Iurea DM, Popa M, Chailan J-F, Tamba BI, Tudorancea I, Peptu CA (2013) Ibuprofen-loaded chitosan/poly(maleic anhydride-alt-vinyl acetate) submicronic capsules for pain treatment. J Bioact Compat Polym 28:368–384. doi: 10.1177/088391151349033610.1177/0883911513490336 ↗
15. Kalantarian P, Najafabadi AR, Haririan I, Vatanara A, Yamini Y, Darabi M, Gilani K (2010) Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary delivery. Int J Nanomed 5:763–770. doi: 10.2147/IJN.S1241510.2147/IJN.S12415 ↗
16. Lamprecht A, Benoit JP (2006) Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release 112:208–213. doi: 10.1016/j.jconrel.2006.02.01410.1016/j.jconrel.2006.02.014 ↗
17. Long JT, Cheang TY, Zhuo SY, Zeng RF, Dai QS, Li HP, Fang S (2014) Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis. J Nanobiotechnol 12:37. doi: 10.1186/s12951-014-0037-510.1186/s12951-014-0037-5 ↗
18. Mi KY, Jinho P, Sangyong J (2012) Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy. Theranostics 2:3–44. doi: 10.7150/thno.346310.7150/thno.3463 ↗
19. Minko T, Rodriguez-Rodriguez L, Pozharov V (2013) Nanotechnology approaches for personalized treatment of multidrug resistant cancers. Adv Drug Deliv Rev 65:1880–1895. doi: 10.1016/j.addr.2013.09.01710.1016/j.addr.2013.09.017 ↗
20. Mora-Huertasa CE, Fessi H, Elaissari A (2010) Polymer-based nanocapsules for drug delivery. Int J Pharm 385:113–142. doi: 10.1016/j.ijpharm.2009.10.01810.1016/j.ijpharm.2009.10.018 ↗
21. Nair KL, Jagadeeshan S, Nair SA, Kumar GS (2011) Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Int J Nanomed 6:1685–1697. doi: 10.2147/IJN.S20165
22. Okamoto H, Shiraki K, Yasuda R, Danjo K, Watanabe Y (2011) Chitosan-interferon-β gene complex powder for inhalation treatment of lung metastasis in mice. J Control Release 150:187–195. doi: 10.1016/j.jconrel.2010.12.00610.1016/j.jconrel.2010.12.006 ↗
23. Roa WH, Azarmi S, Kamal Al-Hallak MHD, Finlay WH, Magliocco AM, Löbenberg R (2010) Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse model. J Control Release 150:49–55. doi: 10.1016/j.jconrel.2010.10.03510.1016/j.jconrel.2010.10.035 ↗
24. Schaffazick SR, Siqueira IR, Badejo AS, Jornada DS, Pohlmann AR, Netto CA, Guterres SS (2008) Incorporation in polymeric nanocapsules improves the antioxidant effect of melatonin against lipid peroxidation in mice brain and liver. Eur J Pharm Biopharm 69:64–71. doi: 10.1016/j.ejpb.2007.11.01010.1016/j.ejpb.2007.11.010 ↗
25. Sukumar UK, Bhushan B, Dubey P, Matai I, Sachdev A, Packirisamy G (2013) Emerging applications of nanoparticles for lung cancer diagnosis and therapy. Int Nano Lett 3:45. doi: 10.1186/2228-5326-3-4510.1186/2228-5326-3-45 ↗
26. Tewa-Tagnea P, Briancon S, Fessi H (2007) Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterization. Eur J Pharm Sci 30:124–13510.1016/j.ejps.2006.10.006 ↗
27. Yang JM, Su WY, Leu TL, Yang MC (2004) Evaluation of chitosan/PVA blended hydrogel membranes. J Membr Sci 236:39–51. doi: 10.1016/j.memsci.2004.02.00510.1016/j.memsci.2004.02.005 ↗